{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:43:24Z","timestamp":1793425404819,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The purpose of this paper is to offer the most important epidemiological indicators of malignant neoplasms in Poland for the year 2019. In 2019, the Polish National Cancer Registry received information on almost 171.2 thousand new cancer cases and 100.3 thousand cancer deaths. The most common male cancers were prostate (20.6%), lung (16.1%), colon (6.8%), bladder (6.4%), and rectal (4.2%) cancers. Age-standardized incidence rates were at 118 per 100,000 for prostate, 89 for lung, 40 for colon, 38 for bladder, and 23 for the rectum. The most prevalent female cancers encompassed breast (22.9%), lung (9.9%), corpus uteri (7.0%), colon (5.9%), and ovary (4.3%). Age-standardized incidence rate was at 95 per 100,000 for breast cancer, 40 for lung 40, 29 for corpus uteri, 24 for colon, and 18 for ovarian cancer. The five leading causes of male cancer deaths were cancer of the lung (27.4%), prostate (10.3%), colon (8.0%), bladder (5.8%), and stomach (5.7%). Age-standardized mortality rates were 100 per 100,000 for lung, 46 for prostate, 32 for colon, 24 for urinary bladder, and 22 for stomach cancer. Most female deaths due to cancer were caused by lung (17.9%), breast (15.1%), colon (7.7%), ovary (6.0%), pancreas (5.7%), and corpus uteri (4.0%) cancers. Age-standardized mortality rates were 39 per 100,000 for lung, 33 for breast, 17 for colon, 13 for ovarian, 13 for pancreatic, and 9 for corpus uteri cancer.<\/jats:p>","DOI":"10.1038\/s41598-022-14779-6","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T16:03:12Z","timestamp":1656345792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Cancer incidence and mortality in Poland in 2019"],"prefix":"10.1038","volume":"12","author":[{"given":"Joanna","family":"Didkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Wojciechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmina Maria","family":"Michalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentino Luciano","family":"Caetano dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"14779_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"14779_CR2","unstructured":"Polish National Health Fund. https:\/\/www.nfz.gov.pl\/aktualnosci\/aktualnosci-centrali\/coraz-wiecej-pieniedzy-przeznaczamy-na-leczenie-nowotworow-i-leki-onkologiczne,7590.html#:~:text=W%202009%20roku%20na%20onkologi%C4%99,%C5%9Bwiadczenia%20zrealizowane%20w%20ramach%20tzw. Accessed 02 June 2022."},{"key":"14779_CR3","unstructured":"Statistics Poland. Mortality and deaths by causes. https:\/\/stat.gov.pl\/en\/topics\/population\/mortality-and-deaths-by-causes-\/mortality-and-deaths-by-causes-in-first-half-of-2021-provisional-data,1,2.html. Accessed on 02 June 2022."},{"key":"14779_CR4","unstructured":"World Bank. Population, total-Poland. https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=PL. Accessed on 14 Mar 2022."},{"key":"14779_CR5","volume-title":"Cancer in Poland in 2019","author":"J Didkowska","year":"2021","unstructured":"Didkowska, J. et al. Cancer in Poland in 2019 (Warsaw, 2021)."},{"key":"14779_CR6","unstructured":"Polish Cancer Registry. https:\/\/www.onkologia.org.pl. Accessed on 02 June 2022."},{"key":"14779_CR7","first-page":"261","volume-title":"Spatial Analysis: Modelling in a GIS Environment","author":"A Getis","year":"1966","unstructured":"Getis, A. et al. Local spatial statistics: An overview. In Spatial Analysis: Modelling in a GIS Environment (eds Longley, P. & Batty, M.) 261\u2013277 (Geoinformation International, 1966)."},{"key":"14779_CR8","unstructured":"Statistics Poland. Size and structure of population by age groups in 1989\u20132020. https:\/\/stat.gov.pl\/en\/topics\/population\/population\/structure-of-the-population,7,1.html. Accessed on 02 Mar 2022."},{"key":"14779_CR9","unstructured":"Finnish Cancer Registry. Cancer Statistics, Prognoses of cancer patients (survival). https:\/\/cancerregistry.fi\/statistics\/cancer-in-finland\/. Accessed on 02 Mar 2022."},{"key":"14779_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"GGlobal Burden of Disease Cancer Collaboration","year":"2019","unstructured":"GGlobal Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 5, 1749\u20131768 (2019).","journal-title":"JAMA Oncol."},{"key":"14779_CR11","unstructured":"Cancer Registry of Norway. Cancer in Norway 2020-Cancer incidence, mortality, survival and prevalence in Norway. https:\/\/www.kreftregisteret.no\/globalassets\/cancer-in-norway\/2020\/cin-2020.pdf."},{"key":"14779_CR12","unstructured":"Pitkaniemi, J., et al. Cancer in Finland 2019. https:\/\/syoparekisteri.fi\/assets\/files\/2021\/07\/Cancer_in_Finland_2019.pdf."},{"key":"14779_CR13","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1080\/0284186X.2020.1789214","volume":"59","author":"J Pitkaniemi","year":"2020","unstructured":"Pitkaniemi, J. et al. Pooling of Finnish population-based health studies: Lifestyle risk factors of colorectal and lung cancer. Acta Oncol. 59, 1338\u20131342 (2020).","journal-title":"Acta Oncol."},{"key":"14779_CR14","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.3390\/ijerph16234820","volume":"16","author":"J Pinkas","year":"2019","unstructured":"Pinkas, J. et al. The prevalence of tobacco and e-cigarette use in Poland: A 2019 nationwide cross-sectional survey. Int. J. Environ. Res. Public Health 16, 4820 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"14779_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jtho.2020.03.035","volume":"15","author":"M Adamek","year":"2020","unstructured":"Adamek, M. et al. Lung cancer in Poland. J. Thorac. Oncol. 15, 1271\u20131276 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"14779_CR16","first-page":"e924702","volume":"26","author":"M Gujski","year":"2020","unstructured":"Gujski, M. et al. Epidemiological analysis of the first 1389 cases of COVID-19 in Poland: A preliminary report. Med. Sci. Monit. 26, e924702 (2020).","journal-title":"Med. Sci. Monit."},{"key":"14779_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4251\/wjgo.v13.i4.238","volume":"13","author":"A Kadakuntla","year":"2021","unstructured":"Kadakuntla, A. et al. Colorectal cancer screening in the COVID-19 era. World J. Gastrointest. Oncol. 13, 238\u2013251 (2021).","journal-title":"World J. Gastrointest. Oncol."},{"key":"14779_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/jamaoncol.2020.7600","volume":"7","author":"Z Bakouny","year":"2021","unstructured":"Bakouny, Z. et al. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol. 7, 458\u2013460 (2021).","journal-title":"JAMA Oncol."},{"key":"14779_CR19","doi-asserted-by":"publisher","first-page":"675038","DOI":"10.3389\/fonc.2021.675038","volume":"11","author":"I Alkatout","year":"2021","unstructured":"Alkatout, I. et al. Has COVID-19 affected cancer screening programs? A systematic review. Front. Oncol. 11, 675038 (2021).","journal-title":"Front. Oncol."},{"key":"14779_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaoncol.2021.0884","volume":"7","author":"RC Chen","year":"2021","unstructured":"Chen, R. C. et al. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 7, 878\u2013884 (2021).","journal-title":"JAMA Oncol."},{"key":"14779_CR21","unstructured":"Fedorenko Z., et al. Cancer in Ukraine 2019\u20132020: Incidence, mortality, prevalence and other relevant statistics-Bulletin of the National Cancer Registry of Ukraine (Kyiv, 2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14779-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14779-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14779-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:19:37Z","timestamp":1669339177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14779-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14779-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10875"}}